Find University Hospitals Doctors

Martin Bocks, MD

Martin Bocks, MD


Pediatric Interventional Cardiology, Cardiology, Pediatric Cardiology

Accepting New Patients

Schedule an Appointment


Are you pregnant or have you had a baby in the last 2 months?


  • Director, Pediatric Cath Lab
  • Associate Professor
  • Program Director, Pediatric Interventional Cardiology

Martin Bocks, MD, is Director of Pediatric Interventional Cardiology at The Congenital Heart Collaborative and the division of Pediatric Cardiology at University Hospitals Rainbow Babies & Children’s Hospital. He also has a secondary appointment within University Hospitals Harrington Heart & Vascular Institute. Dr. Bocks is an Associate Professor, Pediatric Cardiology, Case Western Reserve University School of Medicine.

Dr. Bocks is board certified in Pediatric Cardiology and Internal Medicine. His special interests include transcatheter pulmonary valve implantation and endovascular therapies for congenital heart defects in children and adults. His research interests include pediatric medical device development with particular emphasis on bioresorbable technologies for cardiac catheterization procedures and developing a wireless implantable pressure monitoring system. He was named to the medical staff at UH Rainbow Babies & Children’s Hospital in 2016.

Dr. Bocks has published numerous papers in peer-reviewed medical journals and serves in a review capacity for several periodicals.

Dr. Bocks earned a Bachelor’s degree of science in Biology from University of Michigan in Ann Arbor, Mich., and his medical degree from Wayne State University School of Medicine, Detroit. As a medical student he was inducted into Alpha Omega Alpha Honor Medical Society. He completed residency in Internal Medicine-Pediatrics and fellowships in Pediatric Cardiology and Pediatric Interventional Cardiology at the University of Michigan, Ann Arbor, Mich.

He is a Fellow of the American College of Cardiology, and his other professional memberships include the American Heart Association, Society for Cardiovascular Angiography and Intervention, American Society of Artificial Internal Organs (ASAIO), and the Society for Pediatric Research.


  • Bioresorbable Technologies
  • Congenital Heart Defects
  • Endovascular Therapies
  • Pediatric Cardiac Catheterization
  • Pediatric Medical Device Development
  • Trans-Catheter Pulmonary Valve Implantation


Watch to find out more about this University Hospitals provider.

Languages Spoken


Office Locations

CMC RBC Ste 669

11100 Euclid Ave
Cleveland OH, 44106

Get Directions

UH Ahuja Medical Center

3999 Richmond Rd
Beachwood OH, 44122

Get Directions

UH Broadview Heights Health Center

5901 E Royalton Rd
Broadview Heights OH, 44147

Get Directions

UH Westlake Health Center

960 Clague Rd
Westlake OH, 44145

Get Directions

UH North Ridgeville Health Center

32800 Lorain Rd
North Ridgeville OH, 44039

Get Directions

UH Rainbow Physicians and Surgeons

4137 Boardman Canfield Rd
Canfield OH, 44406

Get Directions

Board Certifications

  • Adult Congenital Heart Disease - American Board of Internal Medicine
  • Pediatric Cardiology - American Board of Pediatrics


Fellowship | Pediatric Interventional Cardiology
Pediatric Interventional Cardiology - University Of Michigan Medical Center/University Of Michigan Health System (2007 - 2008)

Fellowship | Pediatric Cardiology
Pediatric Cardiology - University Of Michigan Medical Center/University Of Michigan Health System (2004 - 2007)

Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - University Of Michigan Medical Center/University Of Michigan Health System (2000 - 2004)

Medical Education
Wayne State University School Of Medicine (2000)

University Of Michigan (1994)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Martin Bocks disclosed the following Outside Relationships with Industry:

  • - Edwards Lifesciences - Consulting payments
Back to Top